CA2135926C - Hexahydrobenzo[a]phenanthridines substituees - Google Patents

Hexahydrobenzo[a]phenanthridines substituees Download PDF

Info

Publication number
CA2135926C
CA2135926C CA002135926A CA2135926A CA2135926C CA 2135926 C CA2135926 C CA 2135926C CA 002135926 A CA002135926 A CA 002135926A CA 2135926 A CA2135926 A CA 2135926A CA 2135926 C CA2135926 C CA 2135926C
Authority
CA
Canada
Prior art keywords
hydrogen
group
compound
formula
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002135926A
Other languages
English (en)
Other versions
CA2135926A1 (fr
Inventor
David E. Nichols
Richard B. Mailman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of North Carolina at Chapel Hill
Purdue Research Foundation
Original Assignee
University of North Carolina at Chapel Hill
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of North Carolina at Chapel Hill, Purdue Research Foundation filed Critical University of North Carolina at Chapel Hill
Priority claimed from PCT/US1993/004971 external-priority patent/WO1993024462A1/fr
Publication of CA2135926A1 publication Critical patent/CA2135926A1/fr
Application granted granted Critical
Publication of CA2135926C publication Critical patent/CA2135926C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002135926A 1992-05-26 1993-05-26 Hexahydrobenzo[a]phenanthridines substituees Expired - Fee Related CA2135926C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88769292A 1992-05-26 1992-05-26
US07/887,692 1992-05-26
PCT/US1993/004971 WO1993024462A1 (fr) 1992-05-26 1993-05-26 Hexahydrobenzo[a]phenanthridines substituees

Publications (2)

Publication Number Publication Date
CA2135926A1 CA2135926A1 (fr) 1993-12-09
CA2135926C true CA2135926C (fr) 2006-02-14

Family

ID=35892253

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002135926A Expired - Fee Related CA2135926C (fr) 1992-05-26 1993-05-26 Hexahydrobenzo[a]phenanthridines substituees

Country Status (1)

Country Link
CA (1) CA2135926C (fr)

Also Published As

Publication number Publication date
CA2135926A1 (fr) 1993-12-09

Similar Documents

Publication Publication Date Title
US20050232870A1 (en) Method of treatment of dopamine-related dysfunction
ES2389253T3 (es) Compuestos heterocíclicos y agentes antitumorales que comprenden los mismos como ingrediente activo
US5420134A (en) Substituted hexahydrobenzo[A]phenanthridines
PL113208B1 (en) Process for preparing novel phthalazine derivatives
KR100295027B1 (ko) 아릴글리신아미드유도체,이의제조방법및활성성분으로서이를함유하는배뇨장해치료제
CZ340499A3 (cs) Substituované izochinoliny a farmaceutický prostředek
JPH01132566A (ja) ４−アミノピリジン誘導体
JPS6225670B2 (fr)
US5047536A (en) Hexahydrobenzo(A)phenanthridine compounds
US5968949A (en) Substituted hydroisoquinoline derivatives and their use as pharmaceuticals
JP3164372B2 (ja) 融合インドール及びキノキサリン誘導体、その製造および使用
JPH0586027A (ja) Ｎｍｄａ拮抗剤
JPH02167279A (ja) アポビンカミン酸誘導体
CA2135926C (fr) Hexahydrobenzo[a]phenanthridines substituees
RU2300532C2 (ru) Производные бензо[g]хинолина для лечения глаукомы и близорукости, способ их получения и фармацевтическая композиция
JPS60197687A (ja) インドロフエナントリジン類
US7423059B2 (en) Pharmaceutically active compounds and methods of use
RU2075477C1 (ru) 1-//2-(динизший алкиламино)алкил/амино/-4-замещенные тиоксантен-9-оны и фармацевтическая композиция, обладающая противоопухолевой активностью
EA003991B1 (ru) Производные 2-аминопиридинов, способ ингибирования синтазы оксида азота, фармацевтические композиции и способы лечения
EP1192161B1 (fr) Chromeno [4,3,2- de ]isoquinolines en tant que ligands puissants de recepteurs de la dopamine
JP2956788B2 (ja) スピロイソインドリン化合物、その製造方法、それを含有する神経症を治療するための医薬およびそれを製造するための中間体
CN102260187B (zh) 取代的氨甲酰基环己甲酸类化合物及其制法和用途
JPH0466568A (ja) 中枢性抗酸化剤化合物
JP3033181B2 (ja) ９―ジアシルアミノテトラヒドロアクリジン誘導体
WO2021098872A1 (fr) Dérivé d'alloprégnénolone phosphonamide, son procédé de préparation et son utilisation pharmaceutique

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed